Distinguishing Pathway to Precision for c-Met and MET Alterations in NSCLC
Season 13, Episode 49, Aug 22, 03:05 PM
Share
Subscribe
In this podcast, experts Erminia Massarelli, MD, PhD, MS; Jorge J. Nieva, MD; Sandip Patel, MD; and Ignacio I. Wistuba, MD, discuss new therapies for patients with c-Met–overexpressing non–small cell lung cancer.